Related Experiment Videos
Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins
A Lasorella1, A Iavarone, M A Israel
1Preuss Laboratory for Molecular Neuro-oncology, Department of Neurological Surgery 94143, USA.
Abstract:
Cells which are highly proliferative typically lack expression of differentiated, lineage-specific characteristics. Id2, a member of the helix-loop-helix (HLH) protein family known to inhibit cell differentiation, binds to the retinoblastoma protein (pRb) and abolishes its growth-suppressing activity. We found that Id2 but not Id1 or Id3 was able to bind in vitro not only pRb but also the related proteins p107 and p130. Also, an association between Id2 and p107 or p130 was observed in vivo in transiently transfected Saos-2 cells. In agreement with these results, expression of Id1 or Id3 did not affect the block of cell cycle progression mediated by pRb. Conversely, expression of Id2 specifically reversed the cell cycle arrest induced by each of the three members of the pRb family. Furthermore, the growth-suppressive activities of cyclin-dependent kinase inhibitors p16 and p21 were efficiently antagonized by high levels of Id2 but not by Id1 Id3. Consistent with the role of p16 as a selective inhibitor of pRb and pRb-related protein kinase activity, p16-imposed cell cycle arrest was completely abolished by Id2. Only a partial reversal of p21-induced growth suppression was observed, which correlated with the presence of a functional pRb. We also documented decreased levels of cyclin D1 protein and mRNA and the loss of cyclin D1-cdk4 complexes in cells constitutively expressing Id2. These data provide evidence for important Id2-mediated alterations in cell cycle components normally involved in the regulatory events of cell cycle progression, and they highlight a specific role for Id2 as an antagonist of multiple tumor suppressor proteins.
Insights
Id2 protein inhibits cell differentiation by binding to tumor suppressor proteins like pRb, p107, and p130. This interaction reverses cell cycle arrest and antagonizes growth suppression, highlighting Id2
Area of Science:
- Molecular Biology
- Cell Cycle Regulation
- Cancer Biology
Background:
- Highly proliferative cells often lack differentiated characteristics.
- Id proteins, including Id2, are helix-loop-helix (HLH) proteins that inhibit cell differentiation.
- The retinoblastoma protein (pRb) family (pRb, p107, p130) are key regulators of cell cycle progression and tumor suppression.
Purpose of the Study:
- To investigate the interaction of Id2 with the pRb family of proteins.
- To determine the effect of Id2 on cell cycle arrest induced by pRb family members.
- To elucidate the role of Id2 in antagonizing tumor suppressor protein functions.
Main Methods:
- In vitro binding assays to assess Id2 interaction with pRb, p107, and p130.
- In vivo co-immunoprecipitation in transiently transfected Saos-2 cells.
- Expression studies to evaluate the impact of Id proteins on cell cycle arrest mediated by pRb family members and cyclin-dependent kinase inhibitors (p16, p21).
- Analysis of cyclin D1 protein, mRNA levels, and cyclin D1-cdk4 complexes.
Main Results:
- Id2, but not Id1 or Id3, binds to pRb, p107, and p130 both in vitro and in vivo.
- Id2 expression reverses cell cycle arrest induced by all three pRb family members.
- Id2 antagonizes the growth-suppressive effects of p16 and p21, with complete reversal of p16-induced arrest.
- Constitutive Id2 expression leads to decreased cyclin D1 and loss of cyclin D1-cdk4 complexes.
Conclusions:
- Id2 plays a specific role in antagonizing multiple tumor suppressor proteins, including the pRb family.
- Id2-mediated alterations in cell cycle components contribute to its function.
- Id2 acts as a key regulator in overcoming cell cycle checkpoints imposed by tumor suppressors.